About This Episode
Nikki Plourde breaks down the trend of Semaglutide and GLP-1 medications, covering the fundamentals every aesthetic practice should know. Part of the Business of Aesthetics podcast collection, Episode 188, “Beyond The Trend of Semaglutide: The 411 of GLPs,” adds useful context for aesthetic-practice professionals. It focuses on the choices that shape trust, satisfaction, and loyalty, helping practices create experiences patients are more likely to value and return to. Listeners can use the conversation to reflect on their current approach, discuss relevant questions with their team, and identify practical next steps.